Pharmacology III MD0806

Description

TABLE OF CONTENTS INTRODUCTION LESSON 1 THE RESPIRATORY SYSTEM INTRODUCTION COMPONENTS AND SUBDIVISIONS OF THE HUMAN RESPIRATORY SYSTEM SUPRALARYNGEAL STRUCTURES LARYNX INFRALARYNGEAL STRUCTURES BREATHING AND BREATHING MECHANISMS IN HUMANS INTRODUCTION COSTAL (THORACIC) BREATHING DIAPHRAGMATIC (ABDOMINAL) BREATHING CONDITIONS AFFECTING THE RESPIRATORY SYSTEM INTRODUCTION PNEUMONIA ASTHMA STATUS ASTHMATICUS EMPHYSEMA PULMONARY EDEMA RESPIRATORY SYSTEM DRUGS INTRODUCTION ANTITUSSIVE AGENTS EXPECTORANT AGENTS ANTITUSSIVE-EXPECTORANT COMBINATION PRODUCTS MUCOLYTICS BRONCHODILATOR AGENTS EXERCISES SOLUTIONS LESSON 2 INTRODUCTION NEED FOR CIRCULATORY SYSTEMS BASIC COMPONENTS OF ANY CIRCULATORY SYSTEM CIRCULATORY SYSTEMS IN THE HUMAN BODY THE HUMAN CARDIOVASCULAR SYSTEM GENERAL BLOOD BLOOD VESSELS BLOOD CLOTTING MECHANISMS OF BLOOD CLOTTING BLOOD PRESSURE ABNORMAL BLOOD PRESSURE DISORDERS WHICH AFFECT THE BLOOD SYSTEM DISORDERS ASSOCIATED WITH THE CIRCULATORY SYSTEM VASCULAR DISORDERS BONE MARROW DEPRESSION THE HEART AND THE SYSTEMIC CIRCULATION OF BLOOD THE HEART THE PROPERTY OF INHERENT RHYTHMICITY THE HEARTBEAT ELECTROLYTES OF SIGNIFICANCE IN HEART FUNCTIONING CARDIAC DISORDERS CARDIOVASCULAR CIRCULATORY PATTERNS THE HUMAN LYMPHATIC SYSTEM GENERAL STRUCTURES OF THE HUMAN LYMPHATIC SYSTEM EXERCISES SOLUTIONS LESSON 3 CONGESTIVE HEART FAILURE AND ITS TREATMENT INTRODUCTION REVIEW OF CONGESTIVE HEART FAILURE TREATMENT OF CONGESTIVE HEART FAILURE ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE INHIBITORS) DIGITALIS AND THE RELATED GLYCOSIDES DIGITALIZING DOSE DIGITALIS PRODUCTS OTHER AGENTS USED IN CONGESTIVE HEART FAILURE THE ANTIARRHYTHMIC AGENTS REVIEW OF CARDIAC ARRHYTHMIAS THE USE OF ANTIARRHYTHMIC DRUGS SPECIFIC ANTIARRHYTHMIC DRUGS ANTIHYPERLIPIDEMIC AGENTS REVIEW OF ATHEROSCLEROSIS DEFINITIONS RISK FACTORS TREATMENT EXERCISES SOLUTIONS LESSON 4 DEFINITIONS INTRODUCTION IMPORTANT TERMS AND THEIR DEFINITIONS VASODILATOR DRUGS INTRODUCTION SMOOTH MUSCLE RELAXANT VASODILATORS AUTONOMIC NERVOUS SYSTEM VASODILATORS EXERCISES SOLUTIONS LESSON 5 DEFINITIONS INTRODUCTION DEFINITIONS COAGULANTS REVIEW OF THE CLOTTING PROCESS COAGULANTS (PROMOTING CLOT FORMATION) ANTICOAGULANTS INTRODUCTION IMPORTANT WARNING ASSOCIATED WITH THE ANTICOAGULANTS ANTICOAGULANT AGENTS HEMATINICS INTRODUCTION HEMATINIC AGENTS STIMULATING FACTORS INTRODUCTION EXERCISES SOLUTIONS LESSON 6 OVERVIEW OF THE UROGENITAL SYSTEMS INTRODUCTION DISCUSSION OF LESSON CONTENT THE HUMAN URINARY SYSTEM INTRODUCTION THE HUMAN URINARY SYSTEM THE KIDNEY HORMONES INVOLVED IN THE FORMATION OF URINE URETERS URINARY BLADDER URETHRA URINARY TRACT DISORDERS INTRODUCTION TO HUMAN GENITAL (REPRODUCTIVE) SYSTEMS SEXUAL DIMORPHISM ADVANTAGES OF DOUBLE PARENTING MAJOR COMPONENT CATEGORIES OF THE GENTIAL SYSTEMS THE HUMAN FEMALE GENITAL (REPRODUCTIVE) SYSTEM PRIMARY SEX ORGANS (OVARIES) SECONDARY SEX ORGANS SECONDARY SEXUAL CHARACTERISTICS MAMMARY GLANDS THE HUMAN MALE GENITAL (REPRODUCTIVE) SYSTEM PRIMARY SEX ORGANS (TESTES) SECONDARY SEX ORGANS SECONDARY SEXUAL CHARACTERISTICS EXERCISES SOLUTIONS LESSON 7 INTRODUCTION TO HYPERTENSION INTRODUCTION TREATMENT OF HYPERTENSION DEFINITION OF ESSENTIAL (PRIMARY) HYPERTENSION CLASSES OF ESSENTIAL HYPERTENSION REVIEW OF IMPORTANT FACTORS RELATING TO HYPERTENSION DIURETICS IN THE TREATMENT OF HYPERTENSION COMBINATION THERAPY IN THE TREATMENT OF HYPERTENSION DRUGS USED IN THE TREATMENT OF HYPERTENSION DRUGS WHICH ACT ON THE SYMPATHETIC NERVOUS SYSTEM BETA ADRENERGIC BLOCKERS SMOOTH MUSCLE RELAXANTS COMBINATION PRODUCTS THE TREATMENT OF A HYPERTENSIVE CRISIS OR EMERGENCY EXERCISES SOLUTIONS LESSON 8 DIURETIC AGENTS INTRODUCTION DEFINTION OF DIURETIC USES OF DIURETICS TYPES OF DIURETICS ANTIDIURETIC AGENTS INTRODUCTION MECHANISM OF ACTION OF ANTIDIURETICS EXAMPLES OF ANTIDIURETIC AGENTS EXERCISES SOLUTIONS LESSON 9 INTRODUCTION GENERAL DEFINITIONS CAUSES OF POISONING THE PHARMACY AND POISON PREVENTION THE POISON PREVENTION PACKAGING ACT OF 1970 THE REQUIREMENTS OF THE POISON PREVENTION PACKAGING ACT OF 1970 EXCEPTIONS TO THE ACT CONSIDERATIONS FOR THE OUTPATIENT PHARMACY THE TREATMENT OF POISONING INTRODUCTION TREATMENT GUIDELINES FOR POISONING VICTIMS POISON CONTROL AND INFORMATION INTRODUCTION POISON INFORMATION/CONTROL CENTERS SUGGESTED REFERENCES TO BE MAINTAINED IN THE PHARMACY IN RELATION TO POISONING INFORMATION CONCLUDING COMMENTS EXERCISES SOLUTIONS ANNEX COMMENT SHEET